• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续性肾脏替代治疗危重症患者的体温与感染。

Body temperature and infection in critically ill patients on continuous kidney replacement therapy.

机构信息

Division of Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Division of Nephrology and Hypertension, Mayo Clinic, MN, Rochester, USA.

出版信息

BMC Nephrol. 2023 Jun 7;24(1):161. doi: 10.1186/s12882-023-03225-y.

DOI:10.1186/s12882-023-03225-y
PMID:37286960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10245466/
Abstract

PURPOSE

Continuous kidney replacement therapy (CKRT) is an increasingly common intervention for critically ill patients with kidney failure. Because CKRT affects body temperature, detecting infections in patients on CKRT is challenging. Understanding the relation between CKRT and body temperature may facilitate earlier detection of infection.

METHODS

We retrospectively reviewed adult patients (≥ 18 years) admitted to the intensive care unit at Mayo Clinic in Rochester, Minnesota, from December 1, 2006, through November 31, 2015, who required CKRT. We summarized central body temperatures for these patients according to the presence or absence of infection.

RESULTS

We identified 587 patients who underwent CKRT during the study period, of whom 365 had infections, and 222 did not have infections. We observed no statistically significant differences in minimum (P = .70), maximum (P = .22), or mean (P = .55) central body temperature for patients on CKRT with infection vs. those without infection. While not on CKRT (before CKRT initiation and after cessation), all three body temperature measurements were significantly higher in patients with infection than in those without infection (all P < .02).

CONCLUSION

Body temperature is insufficient to indicate an infection in critically ill patients on CKRT. Clinicians should remain watchful for other signs, symptoms, and indications of infection in patients on CKRT because of expected high infection rates.

摘要

目的

连续性肾脏替代治疗(CKRT)是一种越来越常见的治疗肾衰竭重症患者的方法。由于 CKRT 会影响体温,因此在接受 CKRT 的患者中检测感染具有挑战性。了解 CKRT 与体温之间的关系可能有助于更早地发现感染。

方法

我们回顾性分析了 2006 年 12 月 1 日至 2015 年 11 月 31 日期间在明尼苏达州罗切斯特市梅奥诊所重症监护病房接受 CKRT 的成年患者(≥18 岁)。我们根据患者是否存在感染,总结了这些患者的中心体温。

结果

我们确定了在研究期间接受 CKRT 的 587 名患者,其中 365 名患者发生了感染,222 名患者没有感染。我们观察到,感染患者与无感染患者的 CKRT 期间的中心体温最低值(P=0.70)、最高值(P=0.22)和平均值(P=0.55)均无统计学差异。而在未接受 CKRT 时(在开始 CKRT 之前和停止 CKRT 之后),所有三种体温测量值在感染患者中均显著高于无感染患者(所有 P<0.02)。

结论

在接受 CKRT 的重症患者中,体温不足以指示感染。由于预期感染率较高,临床医生应密切关注接受 CKRT 的患者的其他感染迹象、症状和指征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c007/10245466/a9b72b8dba3f/12882_2023_3225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c007/10245466/a9b72b8dba3f/12882_2023_3225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c007/10245466/a9b72b8dba3f/12882_2023_3225_Fig1_HTML.jpg

相似文献

1
Body temperature and infection in critically ill patients on continuous kidney replacement therapy.连续性肾脏替代治疗危重症患者的体温与感染。
BMC Nephrol. 2023 Jun 7;24(1):161. doi: 10.1186/s12882-023-03225-y.
2
Real-life effects, complications, and outcomes in 39 critically ill neonates receiving continuous kidney replacement therapy.39 例危重新生儿接受连续肾脏替代治疗的真实生活影响、并发症和结局。
Pediatr Nephrol. 2023 Sep;38(9):3145-3152. doi: 10.1007/s00467-023-05944-8. Epub 2023 Mar 29.
3
Hemodynamic disturbances and oliguria during continuous kidney replacement therapy in critically ill children.危重症儿童连续性肾脏替代治疗期间的血液动力学紊乱和少尿。
Pediatr Nephrol. 2021 Jul;36(7):1889-1899. doi: 10.1007/s00467-020-04804-z. Epub 2021 Jan 12.
4
Low-Dose Continuous Kidney Replacement Therapy and Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Cohort Study.低剂量连续性肾脏替代治疗与急性肾损伤危重症患者的死亡率:一项回顾性队列研究。
Am J Kidney Dis. 2024 Aug;84(2):145-153.e1. doi: 10.1053/j.ajkd.2024.01.526. Epub 2024 Mar 13.
5
Dialysis circuit clotting in critically ill patients with COVID-19 infection.COVID-19 感染危重症患者的透析回路凝血。
BMC Nephrol. 2021 Apr 20;22(1):141. doi: 10.1186/s12882-021-02357-3.
6
Association of continuous kidney replacement therapy timing and mortality in critically ill children.危重症儿童连续性肾脏替代治疗时机与死亡率的相关性。
Pediatr Nephrol. 2024 Jul;39(7):2217-2226. doi: 10.1007/s00467-024-06320-w. Epub 2024 Feb 23.
7
Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.估算美国在 COVID-19 大流行期间连续肾脏替代疗法提供能力短缺。
Am J Kidney Dis. 2020 Nov;76(5):696-709.e1. doi: 10.1053/j.ajkd.2020.07.005. Epub 2020 Jul 28.
8
Hemodynamic instability during connection to continuous kidney replacement therapy in critically ill pediatric patients.危重症儿科患者连续肾脏替代治疗连接期间的血流动力学不稳定。
Pediatr Nephrol. 2022 Sep;37(9):2167-2177. doi: 10.1007/s00467-022-05424-5. Epub 2022 Feb 3.
9
Predictors of successful discontinuation of continuous kidney replacement therapy in a pediatric cohort.儿科患者连续肾脏替代治疗成功撤机的预测因素。
Pediatr Nephrol. 2023 Jul;38(7):2221-2231. doi: 10.1007/s00467-022-05782-0. Epub 2022 Oct 31.
10
Semiautomated Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Observational Study in Young Children.用于持续肾脏替代治疗的半自动局部枸橼酸盐抗凝:一项针对幼儿的观察性研究。
Pediatr Crit Care Med. 2022 Sep 1;23(9):e429-e433. doi: 10.1097/PCC.0000000000002993. Epub 2022 May 17.

本文引用的文献

1
Body temperature trends of critically Ill patients on continuous renal replacement therapy: A single-center retrospective study.危重症患者连续肾脏替代治疗时的体温趋势:一项单中心回顾性研究。
Am J Med Sci. 2022 Oct;364(4):404-408. doi: 10.1016/j.amjms.2022.03.016. Epub 2022 Apr 20.
2
Complications associated with continuous renal replacement therapy.与连续肾脏替代治疗相关的并发症。
Semin Dial. 2021 Nov;34(6):489-494. doi: 10.1111/sdi.12970. Epub 2021 Apr 7.
3
The Association of Platelet Decrease Following Continuous Renal Replacement Therapy Initiation and Increased Rates of Secondary Infections.
连续肾脏替代治疗起始后血小板减少与继发感染率增加的关联。
Crit Care Med. 2021 Feb 1;49(2):e130-e139. doi: 10.1097/CCM.0000000000004763.
4
Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?免疫治疗或细胞治疗后细胞因子释放综合征中的持续肾脏替代治疗?
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000742.
5
Hypothermia during CRRT, a comparative analysis.CRRT 期间的低体温,对比分析。
Acta Anaesthesiol Scand. 2020 Sep;64(8):1162-1166. doi: 10.1111/aas.13616. Epub 2020 Jun 1.
6
Complications During Continuous Renal Replacement Therapy in Critically Ill Neonates.危重新生儿连续性肾脏替代治疗中的并发症。
Blood Purif. 2019;47 Suppl 2:74-80. doi: 10.1159/000496654. Epub 2019 Apr 3.
7
Continuous Renal Replacement Therapy: Who, When, Why, and How.连续性肾脏替代治疗:谁、何时、为何以及如何。
Chest. 2019 Mar;155(3):626-638. doi: 10.1016/j.chest.2018.09.004. Epub 2018 Sep 25.
8
Epidemiology of continuous renal replacement therapy in Korea: Results from the National Health Insurance Service claims database from 2005 to 2016.韩国持续肾脏替代治疗的流行病学:来自2005年至2016年国民健康保险服务理赔数据库的结果。
Kidney Res Clin Pract. 2018 Jun;37(2):119-129. doi: 10.23876/j.krcp.2018.37.2.119. Epub 2018 Jun 30.
9
Delay Within the 3-Hour Surviving Sepsis Campaign Guideline on Mortality for Patients With Severe Sepsis and Septic Shock.严重脓毒症和感染性休克患者的 3 小时存活脓毒症运动指南在死亡率方面的延迟。
Crit Care Med. 2018 Apr;46(4):500-505. doi: 10.1097/CCM.0000000000002949.
10
Infection in critically ill pediatric patients on continuous renal replacement therapy.接受持续肾脏替代治疗的危重症儿科患者的感染情况。
Int J Artif Organs. 2017 May 29;40(5):224-229. doi: 10.5301/ijao.5000587. Epub 2017 May 18.